Business Wire11d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A.
Hosted on MSN5mon
QIAGEN's TB Testing Business Gets New Exposure at Global Summit
QIAGEN’s leading TB blood test, QuantiFERON-TB Gold Plus, remains crucial in detecting latent tuberculosis infection, aiding in breaking the cycle of disease transmission. QIAGEN’s TB Tests in ...
360Dx9d
Qiagen Sues BioMérieux in German Court for Infringing Tuberculosis Test Patent
Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.
Hosted on MSN12mon
Essential and common tests for Tuberculosis diagnosis
Interferon-Gamma IGRAs, such as the QuantiFERON-TB Gold test and the T-SPOT.TB test, measure the release of interferon-gamma by T-cells in response to TB antigens. Unlike TST, IGRAs are not ...
Keene State College3y
New Student Info: Health Forms
T-Spot Lab Test, or Quantiferon Gold Lab Test. These health forms are required before moving into residence halls and starting classes at Keene State College. Health forms are due on June 1, 2022 for ...
Yahoo Finance11d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
covers important innovations in QuantiFERON-TB Gold Plus that is used worldwide for TB detection. "Protecting our intellectual property is essential to ensuring continued innovation in infectious ...